SCHEMBL25487564

SCHEMBL25487564

COC(=O)c1sc2ccc3nc(C)ccc3c2c1NC[C@H](C)N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
KDM4E B2RXH2 8/20 0.34
ALDH1A1 P00352 6/20 0.34
MAPT P10636 5/20 0.34
HSD17B10 Q99714 4/20 0.34
GLA P06280 3/20 0.34
HPGD P15428 3/20 0.34
GAA P10253 2/20 0.34
ALOX15 P16050 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
NCOA1 Q15788 1/20 0.34
RCE1 Q9Y256 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
MAPK1 P28482 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25487554 1.00 P2RX7 (0.38) P2RX7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL25487556 0.92 P2RX7 (0.37) P2RX7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL22895289 0.90 KDM4E (0.34) KDM4EALDH1A1MAPTHSD17B10GLA
SCHEMBL22895320 0.90 KDM4E (0.34) KDM4EALDH1A1MAPTHSD17B10GLA
SCHEMBL29084187 0.86 CYP3A4 (0.34) KDM4EALDH1A1MAPTHSD17B10GLA
SCHEMBL29722863 0.86 CYP3A4 (0.34) KDM4EALDH1A1MAPTHSD17B10GLA
Sulfuric Acid SCHEMBL29084186 0.86 CYP3A4 (0.34) KDM4EALDH1A1MAPTHSD17B10GLA
SCHEMBL25487717 0.84 MAPK1 (0.34) P2RX7KDM4EALDH1A1MAPTHSD17B10
SCHEMBL17581196 0.84 KDM4E (0.40) KDM4EALDH1A1MAPTHSD17B10GLA
SCHEMBL26096163 0.84 KDM4E (0.40) KDM4EALDH1A1MAPTHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655257-B2 MK2 inhibitors, synthesis thereof, and intermediates thereto CELGENE CAR LLC (BM) 2023-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655257-B2 MK2 inhibitors, synthesis thereof, and intermediates thereto WEE2, WEE1, CDK2 P2RX7 3185/4885KDM4E 1054/4885ALDH1A1 3405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.